Article Versions Notes

Feitz WJC, Bouwmeester R, van der Velden TJAM, Goorden S, Licht C, van den Heuvel LPJW, van de Kar NCAJ. The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS. Microorganisms. 2021; 9(10):2157. https://doi.org/10.3390/microorganisms9102157

Feitz, Wouter J. C., Romy Bouwmeester, Thea J. A. M. van der Velden, Susan Goorden, Christoph Licht, Lambert P. J. W. van den Heuvel, and Nicole C. A. J. van de Kar. 2021. "The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS" Microorganisms 9, no. 10: 2157. https://doi.org/10.3390/microorganisms9102157

Feitz, W. J. C., Bouwmeester, R., van der Velden, T. J. A. M., Goorden, S., Licht, C., van den Heuvel, L. P. J. W., & van de Kar, N. C. A. J. (2021). The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS. Microorganisms, 9(10), 2157. https://doi.org/10.3390/microorganisms9102157